Literature DB >> 9661879

Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32.

J Tapper1, L Sarantaus, P Vahteristo, H Nevanlinna, S Hemmer, M Seppälä, S Knuutila, R Butzow.   

Abstract

Germ-line mutations in the BRCA1 and BRCA2 genes confer a predisposition to breast as well as ovarian carcinoma. Except for loss of the respective wild-type allele, somatic genetic changes needed for the progression of inherited ovarian tumors are unknown. A genome-wide search for such alterations was performed by comparative genomic hybridization analysis on BRCA1 and BRCA2 mutation-positive (n = 20) ovarian carcinoma specimens. Comparison with sporadic ovarian carcinomas (n = 20) revealed extensive genetic similarity between the inherited and sporadic carcinomas with the sole exception of a frequent gain of 2q24-q32 in the inherited group, suggesting the presence of an oncogene at 2q24-q32 operating in the absence of BRCA1 function. The overall similarity of gains and losses by comparative genomic hybridization suggests a common main pathway in tumor progression of both inherited and sporadic ovarian carcinomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661879

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.

Authors:  R G Weber; T Pietsch; D von Schweinitz; P Lichter
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.

Authors:  H Lassus; R Salovaara; L A Aaltonen; R Butzow
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  DNA copy number changes in thyroid carcinoma.

Authors:  S Hemmer; V M Wasenius; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

4.  Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells.

Authors:  Liu Meimei; Li Peiling; Li Baoxin; Li Changmin; Zhuang Rujin; Hu Chunjie
Journal:  Med Oncol       Date:  2010-01-07       Impact factor: 3.064

Review 5.  Advanced molecular cytogenetics in human and mouse.

Authors:  Kathleen Dorritie; Cristina Montagna; Michael J Difilippantonio; Thomas Ried
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

6.  Genomic structure of chromosome 17 deletions in BRCA1-associated ovarian cancers.

Authors:  Karen M Chisholm; Barbara A Goff; Rochelle Garcia; Mary-Claire King; Elizabeth M Swisher
Journal:  Cancer Genet Cytogenet       Date:  2008-05

Review 7.  Comparative genomic hybridization and chromosomal instability in solid tumours.

Authors:  P H Rooney; G I Murray; D A Stevenson; N E Haites; J Cassidy; H L McLeod
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

8.  Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivity.

Authors:  Jean Bouquet De Jolinière; Jean Marc Bernard Ayoubi; Luca Gianaroli; Jean Bernard Dubuisson; Jean Gogusev; Anis Feki
Journal:  Front Surg       Date:  2014-05-27

9.  Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution.

Authors:  Francesca Micci; Lisbeth Haugom; Terje Ahlquist; Vera M Abeler; Claes G Trope; Ragnhild A Lothe; Sverre Heim
Journal:  J Oncol       Date:  2009-09-15       Impact factor: 4.375

10.  Genomic profile of ovarian carcinomas.

Authors:  Francesca Micci; Lisbeth Haugom; Vera M Abeler; Ben Davidson; Claes G Tropé; Sverre Heim
Journal:  BMC Cancer       Date:  2014-05-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.